BioVoice News September 2017 Issue 4 Volume 2 | Page 16

cover story KEY DRIVERS FOR THE VACCINE MARKET • Relatively low cost of manufacturing • Reasonable R&D expenditure • Leading edge technology • Combination vaccines • Low cost of clinical trials • Abundant skilled manpower and scientists • Huge demand in the local market • Blockbuster potential of new vaccines 16 BioVoiceNews | September 2017